1. Home
  2. EXEL vs PCTY Comparison

EXEL vs PCTY Comparison

Compare EXEL & PCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • PCTY
  • Stock Information
  • Founded
  • EXEL 1994
  • PCTY 1997
  • Country
  • EXEL United States
  • PCTY United States
  • Employees
  • EXEL N/A
  • PCTY N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • PCTY Computer Software: Prepackaged Software
  • Sector
  • EXEL Health Care
  • PCTY Technology
  • Exchange
  • EXEL Nasdaq
  • PCTY Nasdaq
  • Market Cap
  • EXEL 10.4B
  • PCTY 8.5B
  • IPO Year
  • EXEL 2000
  • PCTY 2014
  • Fundamental
  • Price
  • EXEL $38.94
  • PCTY $141.11
  • Analyst Decision
  • EXEL Buy
  • PCTY Buy
  • Analyst Count
  • EXEL 22
  • PCTY 17
  • Target Price
  • EXEL $44.10
  • PCTY $222.31
  • AVG Volume (30 Days)
  • EXEL 2.9M
  • PCTY 538.2K
  • Earning Date
  • EXEL 11-04-2025
  • PCTY 11-04-2025
  • Dividend Yield
  • EXEL N/A
  • PCTY N/A
  • EPS Growth
  • EXEL 81.76
  • PCTY 10.74
  • EPS
  • EXEL 2.08
  • PCTY 4.02
  • Revenue
  • EXEL $2,230,005,000.00
  • PCTY $1,595,221,000.00
  • Revenue This Year
  • EXEL $9.14
  • PCTY $10.39
  • Revenue Next Year
  • EXEL $12.59
  • PCTY $8.35
  • P/E Ratio
  • EXEL $18.75
  • PCTY $35.10
  • Revenue Growth
  • EXEL 10.73
  • PCTY 13.74
  • 52 Week Low
  • EXEL $31.18
  • PCTY $140.49
  • 52 Week High
  • EXEL $49.62
  • PCTY $223.80
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 50.54
  • PCTY 25.28
  • Support Level
  • EXEL $33.76
  • PCTY $151.13
  • Resistance Level
  • EXEL $40.63
  • PCTY $154.05
  • Average True Range (ATR)
  • EXEL 1.30
  • PCTY 3.14
  • MACD
  • EXEL 0.17
  • PCTY -0.35
  • Stochastic Oscillator
  • EXEL 75.47
  • PCTY 4.17

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About PCTY Paylocity Holding Corporation

Founded in 1997, Paylocity is a cloud-based human capital management and payroll platform servicing midmarket customers. The company's average client size is around 150 employees. Its products help with recruiting and onboarding, payroll, time and labor, human resources, benefits, learning, and performance and compensation workflows. In fiscal 2025, the company generated over $1.5 billion in revenue across more than 41,000 customers.

Share on Social Networks: